AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered, structured, and analyzed by LLMs. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
AI in Drug Discovery: 2025 in Review — Insilico Medicine Hits Phase IIa Milestone
Insilico Medicine achieved the first positive Phase IIa results for a fully AI-designed drug, while the Recursion-Exscientia merger created an end-to-end AI drug discovery platform. Over 200 AI-discovered drugs are now in development.
AI Drug Discovery Reaches 173 Active Clinical Programs With New FDA Framework
A comprehensive analysis counts 173 active AI-discovered drug programs in clinical development, supported by an evolving FDA framework for credibility assessment of AI models used in drug discovery.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
Claude analyzes each source, extracts key information, and produces structured articles with categories, tags, and analytical context.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.